News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
293,844 Results
Type
Article (15254)
Company Profile (101)
Press Release (278489)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (94843)
Career Advice (497)
Deals (16291)
Drug Delivery (74)
Drug Development (43752)
Employer Resources (58)
FDA (7336)
Job Trends (6766)
News (165753)
Policy (15506)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (494)
Accelerated approval (2)
Adcomms (8)
Allergies (38)
Alliances (24098)
ALS (40)
Alzheimer's disease (539)
Antibody-drug conjugate (ADC) (52)
Approvals (7380)
Artificial intelligence (121)
Autoimmune disease (12)
Automation (5)
Bankruptcy (156)
Best Places to Work (4930)
BIOSECURE Act (10)
Biosimilars (62)
Biotechnology (41)
Bladder cancer (38)
Brain cancer (16)
Breast cancer (116)
Cancer (899)
Cardiovascular disease (87)
Career advice (433)
Career pathing (14)
CAR-T (48)
Cell therapy (149)
Cervical cancer (9)
Clinical research (37408)
Collaboration (392)
Compensation (186)
Complete response letters (19)
COVID-19 (906)
CRISPR (22)
C-suite (158)
Cystic fibrosis (41)
Data (902)
Denatured (15)
Depression (18)
Diabetes (111)
Diagnostics (1690)
Digital health (1)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (66)
Drug pricing (67)
Drug shortages (13)
Duchenne muscular dystrophy (49)
Earnings (36036)
Editorial (13)
Employer branding (5)
Employer resources (52)
Events (41531)
Executive appointments (506)
FDA (7912)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (302)
Gene editing (50)
Generative AI (9)
Gene therapy (136)
GLP-1 (384)
Government (1461)
Grass and pollen (3)
Guidances (17)
Healthcare (4370)
Huntington's disease (6)
IgA nephropathy (15)
Immunology and inflammation (42)
Indications (18)
Infectious disease (949)
Inflammatory bowel disease (60)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (50)
Interviews (62)
IPO (6550)
IRA (29)
Job creations (2094)
Job search strategy (393)
Kidney cancer (8)
Labor market (14)
Layoffs (216)
Leadership (5)
Legal (3524)
Liver cancer (30)
Lung cancer (123)
Lymphoma (82)
Machine learning (1)
Management (20)
Manufacturing (179)
MASH (46)
Medical device (2378)
Medtech (2380)
Mergers & acquisitions (9975)
Metabolic disorders (326)
Multiple sclerosis (27)
NASH (16)
Neurodegenerative disease (32)
Neuropsychiatric disorders (11)
Neuroscience (776)
NextGen: Class of 2025 (1719)
Non-profit (738)
Northern California (1034)
Now hiring (9)
Obesity (174)
Opinion (135)
Ovarian cancer (32)
Pain (56)
Pancreatic cancer (27)
Parkinson's disease (64)
Partnered (7)
Patents (124)
Patient recruitment (56)
Peanut (14)
People (31232)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (9135)
Phase II (15425)
Phase III (15413)
Pipeline (619)
Policy (75)
Postmarket research (1504)
Preclinical (3485)
Press Release (28)
Prostate cancer (59)
Psychedelics (14)
Radiopharmaceuticals (131)
Rare diseases (212)
Real estate (2711)
Recruiting (19)
Regulatory (11532)
Reports (17)
Research institute (641)
Resumes & cover letters (60)
Rett syndrome (4)
RNA editing (2)
RSV (10)
Schizophrenia (44)
Series A (54)
Series B (30)
Service/supplier (3)
Sickle cell disease (34)
Southern California (880)
Special edition (6)
Spinal muscular atrophy (99)
Sponsored (6)
Startups (1700)
State (2)
Stomach cancer (4)
Supply chain (34)
Tariffs (26)
The Weekly (33)
United States (9194)
Vaccines (226)
Venture capitalists (17)
Weight loss (112)
Women's health (14)
Worklife (3)
Date
Today (14)
Last 7 days (278)
Last 30 days (1086)
Last 365 days (14649)
2025 (4626)
2024 (15499)
2023 (17151)
2022 (22366)
2021 (23155)
2020 (21527)
2019 (16580)
2018 (13010)
2017 (15297)
2016 (14281)
2015 (16845)
2014 (13267)
2013 (11189)
2012 (11989)
2011 (12492)
2010 (11404)
Location
Africa (325)
Alabama (16)
Alaska (2)
Arizona (59)
Arkansas (3)
Asia (22174)
Australia (2976)
California (2318)
Canada (1051)
China (276)
Colorado (104)
Connecticut (89)
Delaware (70)
Europe (43765)
Florida (379)
Georgia (61)
Idaho (9)
Illinois (233)
India (18)
Indiana (141)
Iowa (3)
Japan (99)
Kansas (62)
Kentucky (14)
Louisiana (2)
Maine (8)
Maryland (300)
Massachusetts (1843)
Michigan (42)
Minnesota (127)
Missouri (33)
Montana (9)
Nebraska (8)
Nevada (12)
New Hampshire (15)
New Jersey (905)
New Mexico (7)
New York (713)
North Carolina (466)
North Dakota (3)
Northern California (1034)
Ohio (65)
Oklahoma (4)
Oregon (19)
Pennsylvania (572)
Puerto Rico (8)
Rhode Island (11)
South America (512)
South Carolina (3)
South Dakota (1)
Southern California (880)
Tennessee (43)
Texas (302)
Utah (62)
Virginia (78)
Washington D.C. (32)
Washington State (154)
West Virginia (2)
Wisconsin (25)
293,844 Results for "pivot pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Petros Pharmaceuticals’ Proprietary Technology Demonstrates Positive Data in Pivotal Study
February 26, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity
April 7, 2025
·
8 min read
Press Releases
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
March 14, 2025
·
4 min read
Press Releases
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
February 10, 2025
·
1 min read
Press Releases
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
April 7, 2025
·
13 min read
Press Releases
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding
March 31, 2025
·
7 min read
Press Releases
Carthera Reaches Recruitment Milestone in SONOBIRD Pivotal Trial for Recurrent Glioblastoma
April 22, 2025
·
5 min read
Press Releases
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
February 17, 2025
·
3 min read
Press Releases
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
January 21, 2025
·
3 min read
Duchenne muscular dystrophy
Regenxbio Gears Up to Challenge Sarepta in DMD as Gene Therapy Advances to Pivotal Studies
Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for 2026—potentially posing a threat to Sarepta’s Elevidys.
November 19, 2024
·
2 min read
·
Tristan Manalac
1 of 29,385
Next
